Physician profile
Brian E Mussett
NPI 1730146150
$5,709.39
in general payments reported to CMS, 2019-2025
27 companies · $1,469 in 2025
The $1,469 reported for 2025 was more than what 77% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $305 · 2021: $1,303 · 2022: $663 · 2023: $542 · 2024: $1,125 · 2025: $1,469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,114 · Education: $21.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,113.74 |
| Education | $21.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,795.19 | 2021-2025 | Puraply Wound Matrix, Puraply, Puraply Antimicrobial |
| Smith+Nephew, INC. | $1,441.30 | 2019-2025 | Grafix Pl, Stravix, Grafix |
| Bioventus LLC | $381.90 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Paratek Pharmaceuticals, INC. | $228.04 | 2022-2025 | Nuzyra |
| Averitas Pharma INC. | $196.74 | 2023-2024 | Qutenza |
| Misonix INC | $167.66 | 2020-2021 | |
| Integra Lifesciences Corporation | $148.55 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $140.61 | 2025 | Na |
| Nabriva Therapeutics, Plc | $138.24 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $127.28 | 2019 | |
| Pfizer INC. | $122.49 | 2019-2020 | |
| Lifenet Health | $118.48 | 2025 | Theragenesis Wound Matrix |
| Bone Support INC. | $111.62 | 2024 | Ceramentbone Void Filler, Cerament G |
| Solventum Corporation | $104.49 | 2025 | Prevena, V.A.C. Veraflo |
| Abbott Laboratories | $100.30 | 2019-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $78.24 | 2020-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Stryker Corporation | $54.67 | 2025 | Citrefix |
| Hydrofera LLC | $44.00 | 2024 | Hydrofera Blue |
| Tactile Systems Technology INC | $29.68 | 2025 | Nimbl, Flexitouch Plus |
| Treace Medical Concepts, INC. | $26.48 | 2023 | |
| Zimmer Biomet Holdings, INC. | $24.16 | 2019 | |
| Polynovo North America LLC | $23.79 | 2024 | Novosorb Btm |
| Baudax Bio INC. | $23.12 | 2022 | |
| Triad Life Sciences INC. | $22.59 | 2022 | |
| Hartmann USA, INC. | $20.56 | 2023 | Zetuvit Plus |
| Ebi, LLC | $20.50 | 2025 | Biomet Ebi Bone Healing System |
| Orthofix Medical, INC. | $18.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Mussett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.